Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Synergy Pharmaceuticals Inc (SGYPQ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Synergy Pharma historical data, for real-time data please try another search
0.006 0.000    0.00%
01/05 - Delayed Data. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 0.006 - 0.007
Synergy Pharma 0.006 0.000 0.00%

SGYPQ Interactive Chart

 
Get instant access to a free live interactive chart for the Synergy Pharmaceuticals Inc stock. You have the option to change the appearance of the charts by varying the time scale, chart type, zooming in to different sections and adding new studies or indicators such as RSI, MACD, EMA, Bollinger Bands, Fibonacci retracements and many more. You can save your Synergy Pharma stock studies and create your own systems as well as having the option to set the colors of each object on the chart.
Sign In / Free Sign Up now to save your chart settings.
press ESC to exit fullscreen mode
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SGYPQ Comments

Write your thoughts about Synergy Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Pedro Da Silva
Pedro Da Silva Apr 01, 2019 3:04PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
seems like it's done.... at least for now, and maybe forever.  I guess i will just hold it...
Gerald Braffet
Gerald Braffet Mar 07, 2019 10:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Is this stock done?
Duane Pressley
Duane Pressley Mar 04, 2019 7:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sell now cut your losses it will drop to .01 or below but by April or May it will be near 50 cents. If it gets delisted you will be notified you have 2 options hold your shares and hope it starts trading again or they should buy back your shares you may have to take legal action but bankruptcy delisting and violation delisting are different. Good luck.
nabaraj Subedi
nabaraj Subedi Mar 04, 2019 7:52AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
SGYP did not sell Uroguanylin which is the foundation for its GI platform. https://www.synergypharma.com/research-and-development/uroguanylin
Jonathan Harris
Jonathan Harris Mar 02, 2019 4:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why is Robinhood @ .03???
nabaraj Subedi
nabaraj Subedi Mar 02, 2019 4:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
SGYP price will be > 0.07 on monday.
nabaraj Subedi
nabaraj Subedi Mar 02, 2019 6:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Anybody predicted upcoming monday target price of SGYP?
wong yong teck
wong yong teck Feb 27, 2019 10:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wow, risk equal return
wong yong teck
wong yong teck Feb 27, 2019 10:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wow, risk equal return
netti botwe
netti botwe Feb 26, 2019 6:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
down almost 100%. lol. too risky. this could wipe an account.
Jason Chen
Jason Chen Feb 26, 2019 6:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what just happened
Khalsa Singh
Khalsa Singh Feb 26, 2019 6:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Had a 1000 stock at .24... almost gone.
Faisal Alrefaei
Faisal Alrefaei Feb 25, 2019 4:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
game is over
Dima Korinny
Dima Korinny Feb 10, 2019 11:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bids deadline - Feb 23rd. don't miss
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email